The study concluded that LEPR Q223R (rs1137101) and A allele in the K109R (rs1137100) polymorphisms might confer a significant risk and an independent risk, respectively, for both NAFLD and CAD [40]. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.